Published in Am Rev Respir Dis on September 01, 1989
Fatal isoniazid-induced hepatitis. Its risk during chemoprophylaxis. West J Med (1993) 1.46
Isoniazid-related fatal hepatitis. West J Med (1996) 1.17
Tuberculosis: 9. Treatment. CMAJ (1999) 1.08
Tuberculosis in the 1990s. Issues for primary care physicians. Can Fam Physician (1995) 0.98
Short-course therapy for tuberculosis in infants and children. Infectious Diseases and Immunization Committee, Canadian Paediatric Society. CMAJ (1994) 0.98
Antituberculosis drug-induced hepatotoxicity in children. Pediatr Rep (2011) 0.97
Hepatotoxic effects of therapies for tuberculosis. Nat Rev Gastroenterol Hepatol (2010) 0.92
Isoniazid hepatotoxicity requiring liver transplantation. Dig Dis Sci (2014) 0.80
Risk Factors of Hepatotoxicity During Anti-tuberculosis Treatment. Med J Armed Forces India (2011) 0.79
Isoniazid toxicity in a 5-year-old boy. CMAJ (2013) 0.78
Hepatotoxicity of antituberculosis drugs. Thorax (1996) 0.75
Isoniazid-induced severe hepatotoxicity: an infrequent but preventable cause of liver failure in children treated for latent tuberculosis infection. Clin Med Insights Pediatr (2011) 0.75
Acute and Fatal Isoniazid-Induced Hepatotoxicity: A Case Report and Review of the Literature. Case Rep Infect Dis (2016) 0.75
Pregnancy does not mean that patients with tuberculosis must stop treatment. BMJ (1999) 0.75
Treatment strategies in the prevention of tuberculosis. West J Med (1992) 0.75
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science (1989) 18.79
The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men. Ann Intern Med (1982) 3.69
HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J Immunol (1993) 3.42
A single antigenomic open reading frame of the hepatitis delta virus encodes the epitope(s) of both hepatitis delta antigen polypeptides p24 delta and p27 delta. J Virol (1988) 2.99
Heme biosynthesis in intermittent acute prophyria: decreased hepatic conversion of porphobilinogen to porphyrins and increased delta aminolevulinic acid synthetase activity. Proc Natl Acad Sci U S A (1970) 2.33
Extra- and intrahepatic portal hypertension without cirrhosis (hepatoportal sclerosis). Ann Surg (1965) 2.10
Liver transplantation for advanced liver disease with alpha-1-antitrypsin deficiency. N Engl J Med (1980) 2.00
The reciprocal relation between caloric intake and the degree of hyperbilirubinemia in Gilbert's syndrome. N Engl J Med (1970) 1.96
Mutliple hepatitis viruses in multiple attacks of acute viral hepatitis. N Engl J Med (1977) 1.95
Liver allograft. Its use in chronic active hepatitis with macronodular cirrhosis, hepatitis B surface antigen. Arch Surg (1979) 1.80
Decreased red cell uroporphyrinogen I synthetase activity in intermittent acute porphyria. J Clin Invest (1972) 1.80
Fulminant B viral hepatitis: role of delta agent. Gastroenterology (1984) 1.74
Subdeterminants d and y of hepatitis B antigen as epidemiologic markers. Am J Epidemiol (1972) 1.70
Prevalence of delta-antibody among chronic hepatitis B virus infected patients in the Los Angeles area: its correlation with liver biopsy diagnosis. Gastroenterology (1983) 1.70
Etiology of sporadic hepatitis B surface antigen-negative hepatitis. Ann Intern Med (1977) 1.63
Diagnostic features of tuberculous peritonitis in the absence and presence of chronic liver disease: a case control study. Am J Med (1996) 1.62
Liver replacement for alpha1-antitrypsin deficiency. Surgery (1977) 1.53
Percutaneous transhepatic cholangiography. An improved technique. JAMA (1975) 1.51
Long term follow-up studies of patients surviving fluminant viral hepatitis. Gastroenterology (1974) 1.51
Hepatitis B immune globulin as a prophylactic measure for spouses exposed to acute type B hepatitis. N Engl J Med (1975) 1.50
Controlled trial of exchange-transfusion therapy in fulminant hepatitis. Lancet (1973) 1.50
Viral hepatitis: clinical aspects. Am J Med Sci (1976) 1.45
Hepatitis B virus infection in dentists. N Engl J Med (1975) 1.44
Hepatitis C antibodies in patients with alcoholic liver disease commonly have an identifiable risk factor. J Clin Gastroenterol (1992) 1.38
Direct transhepatic measurement of portal vein pressure using a thin needle. Comparison with wedged hepatic vein pressure. Gastroenterology (1977) 1.38
Characterization of a reproducible rat model of hepatic veno-occlusive disease. Hepatology (1999) 1.29
Chronic liver disease after acute non-A, non-B viral hepatitis. Gastroenterology (1979) 1.28
Porphyria cutanea tarda. A study of the effect of phlebotomy. N Engl J Med (1968) 1.28
Peliosis hepatis in a patient with human immunodeficiency virus infection. AJR Am J Roentgenol (1991) 1.23
Hepatits A virus infection in fulminant hepatitis and chronic active hepatitis. Gastroenterology (1978) 1.19
Hepatitis B surface antigen in pancreatic and biliary secretions. Gastroenterology (1980) 1.17
Results of a 12-year randomized trial of portacaval shunt in patients with alcoholic liver disease and bleeding varices. Gastroenterology (1981) 1.15
A comparative study of hepatitis B viral markers in the family members of Asian and non-Asian patients with hepatitis B surface antigen-positive hepatocellular carcinoma and with chronic hepatitis B infection. J Infect Dis (1979) 1.15
Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis. Am J Gastroenterol (1999) 1.13
Functional renal failure with cirrhosis. The effect of plasma expansion therapy. Medicine (Baltimore) (1967) 1.12
Porphyria cutanea tarda symptomatica (PCT-S). A study of the effect of phlebotomy therapy. Arch Dermatol (1965) 1.11
Fulminant hepatitis A in intravenous drug users with chronic liver disease. Ann Intern Med (1989) 1.09
Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C. Gastroenterology (1994) 1.09
Letter: Randomization of corticosteroid therapy in fulminant hepatitis. N Engl J Med (1976) 1.08
Results of a randomized trial of end-to-side portacaval shunt and distal splenorenal shunt in alcoholic liver disease and variceal bleeding. Gastroenterology (1986) 1.08
Relation of alpha-fetoprotein in acute hepatitis to severity and prognosis. Ann Intern Med (1974) 1.08
Appraisal of the mortality in acute fulminant viral hepatitis. N Engl J Med (1968) 1.07
Serologic characterization of patients with two episodes of acute viral hepatitis. Am J Med (1975) 1.07
Survival in patients with postnecrotic cirrhosis and Laennec's cirrhosis undergoing therapeutic portacaval shunt. Gastroenterology (1977) 1.06
Distribution of hepatitis B antigenic determinants in different forms of viral hepatitis. J Infect Dis (1972) 1.05
Epidemic non-A, non-B hepatitis in patients from Pakistan. Ann Intern Med (1987) 1.03
A pilot randomized, controlled trial of the effect of iron depletion on long-term response to alpha-interferon in patients with chronic hepatitis C. J Hepatol (1998) 1.02
Spontaneous rupture of nonparasitic cyst of the liver. Gastroenterology (1989) 1.01
Support of sinusoidal endothelial cell glutathione prevents hepatic veno-occlusive disease in the rat. Hepatology (2000) 1.01
Clinical comparison of end-to-side and side-to-side portacaval shunt. N Engl J Med (1966) 1.01
The persistence of hepatitis A IgM antibody after acute clinical hepatitis A. Hepatology (1984) 0.99
Natural course of delta superinfection in chronic hepatitis B virus-infected patients: histopathologic study with multiple liver biopsies. Hepatology (1986) 0.99
A controlled study of the safety of pooled plasma stored in the liquid state at 30-32 C for six months. Transfusion (1968) 0.99
Hepatitis B. Risk of infection from antigen-positive medical personnel and patients. JAMA (1975) 0.98
Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection. J Viral Hepat (2001) 0.98
The "glucose effect" in erythropoietic protoporphyria. Arch Intern Med (1968) 0.97
Delta agent superinfection. Rapidly progressive liver disease in a hepatitis B virus carrier. Arch Pathol Lab Med (1985) 0.96
Urine and serum zinc abnormalities in disease of the liver. Am J Clin Pathol (1965) 0.96
Prevalence of hepatitis delta (delta) virus infection. A seroepidemiologic study. West J Med (1988) 0.94
Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit. Am J Gastroenterol (2001) 0.93
Spontaneous reactivation in chronic hepatitis B: patterns and natural history. J Clin Gastroenterol (1990) 0.93
Experience with human immunodeficiency virus infection in patients with hepatitis B virus and hepatitis delta virus infections in Los Angeles, 1977-1985. Am J Epidemiol (1988) 0.93
Hepatocellular carcinoma in a case of Wilson's disease. Liver (1992) 0.93
Prednisone therapy of acute alcoholic hepatitis. Report of a controlled trial. Ann Intern Med (1973) 0.92
Acquired porphyria cutanea tarda, primary refractory anemia, and hepatic siderosis. Report of a case. Arch Intern Med (1966) 0.92
Possible case of HBV-2 infection. Lancet (1988) 0.92
Effect of chloroquine on hepatic uroporphyrin metabolism in patients with porphyria cutanea tarda. Medicine (Baltimore) (1966) 0.91
Effect of short-term prednisone therapy on aminotransferase levels and hepatitis B virus markers in chronic type B hepatitis. Gastroenterology (1983) 0.90
Double-blind, controlled trial of propylthiouracil in patients with severe acute alcoholic hepatitis. Gastroenterology (1982) 0.90
Hepatitis C virus antibodies in acute icteric and chronic non-A, non-B hepatitis. Gastroenterology (1991) 0.90
Hemolytic anemia in Wilson disease: clinical findings and biochemical mechanisms. Am J Hematol (1980) 0.88
Tubular dysfunction in the deeply jaundiced patient with hepatorenal syndrome. Hepatology (1985) 0.88
Ultrasonographic diagnosis of acute alcoholic hepatitis 'pseudoparallel channel sign' of intrahepatic artery dilatation. Gastroenterology (1993) 0.88
Delta hepatitis in the Los Angeles area: a report of 126 cases. Ann Intern Med (1986) 0.87
Glomerular tubular reflux--a morphologic renal lesion associated with the hepatorenal syndrome. Hepatology (1984) 0.87
Porphyria cutanea tarda. Remission following chloroquine administration without adverse effects. Arch Dermatol (1968) 0.87
Acute hepatitis induced by bupropion. Dig Dis Sci (2000) 0.87
Chronic hepatitis. Med Clin North Am (1975) 0.86
Acute intermittent porphyria: effect of diet and griseofulvin. Medicine (Baltimore) (1967) 0.85
Nonpercutaneous spread of delta infection. J Infect Dis (1985) 0.85
High-density lipoprotein cholesterol and liver disease. Hepatology (1983) 0.84
A distinctive perivenular hepatic lesion associated with heart failure. Am J Clin Pathol (1980) 0.84
The Hoesch test: bedside screening for urinary porphobilinogen in patients with suspected porphyria. Clin Chem (1974) 0.84
Correlation of IgM anti-hepatitis D virus (HDV) to HDV RNA in sera of chronic HDV. Hepatology (1989) 0.84
Clinical significance of concomitant hepatitis C infection in patients with alcoholic liver disease. Hepatology (1994) 0.83
Sex and strain differences in response to cocaine. Biochem Pharmacol (1984) 0.81
Effect of iron depletion on long-term response to interferon-alpha in patients with chronic hepatitis C who previously did not respond to interferon therapy. Am J Gastroenterol (1997) 0.81
Acute delta hepatitis without circulating HBsAg. Gut (1985) 0.81
Failure to transfer-factor therapy in chronic active type B hepatitis. N Engl J Med (1976) 0.81
Delta agent and hepatitis B. Ann Intern Med (1983) 0.81
Hepatitis B virus DNA in fulminant hepatitis B. Ann Intern Med (1986) 0.81
Evaluation of anti-HBc IgM estimation by radioimmunoassay for anti-HBc on column separated IgM. Ann Clin Lab Sci (1987) 0.80
Portal vein thrombosis complicating endoscopic variceal sclerotherapy. Convincing further evidence. Dig Dis Sci (1991) 0.80
Enzyme changes and morphometric analysis of bile ducts in experimental bile duct obstruction. Clin Chim Acta (1979) 0.80
HDV infection in the Los Angeles area. Prog Clin Biol Res (1987) 0.80
Clinical significance of hepatitis C viral RNA status and its correlation to antibodies to structural HCV antigens in anti-HCV reactive patients with normal liver tests. J Med Virol (1996) 0.80
Differences in intrahepatic portal-systemic shunting in alcoholic and nonalcoholic liver disease as assessed by liver scan, portal pressure, and E. coli antibodies. Dig Dis Sci (1979) 0.80
Prognostic implications of the e antigen of hepatitis B virus. JAMA (1977) 0.79
Successful renal transplantation in patients positive for hepatitis B antigen. N Engl J Med (1974) 0.79